So far, the platform has, among other things, enabled the automation of data registration, streamlined internal case handling, and distributed quality-assured drug information to the Norwegian healthcare sector.
In addition, the platform has introduced several new features in the Norwegian healthcare system, such as approval and information systems where health professionals can report their experiences with different preparations, and where citizens can read about dosing and side effects associated with their medication.
DELE is being developed in accordance with current international standards for design and security, and the platform also enables pharmaceutical companies to update information about their products online themselves. This simplifies the registration process and makes it easier to maintain updated information about medicines.
Having spent all of 2021 conducting extensive analysis work, the first part of DELE was completed in 2022 – among other things, with new professional systems for pharmacy licenses, business permits, and supervision. Work is expected to continue until 2024.
The platform is thus still in its early stages, but Christoffer Daae-Qvale is optimistic about the project’s future prospects.
»It’s still ‘early days’, but we are optimistic and believe that we will be able to satisfy the increasing demand for structured data even more easily in the future. It all looks promising,« says Christoffer Daae-Qvale.